
|Articles|January 24, 2005
New antimuscarininc agent approved for overactive bladder
Overactive bladder (OAB) is a condition that affects an estimated 33 million Americans. At least 16% of the population over the age of 40 is affected by the chronic symptoms of OAB.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Accepts Sandoz Applications for Generic Tirzepatide
2
Amazon, Fleming Initiative Partner to Combat Antimicrobial Resistance
3
Naloxone Access Continuously Improves as Gaps Persist in Pharmacy
4
Advocacy in Action: How Community Pharmacists Can Drive Change
5































